Molecular Diagnostics Market Research Reports & Industry Analysis
Modern technology, however, is beginning to give new meaning to the term “molecular diagnostics.” These new technologies have massive potential for the typing of diseases (e.g., such as in cancer and viral infections), determination of variations in disease state based on therapeutic administration, and the development of newer and more effective therapeutics. Reports in this category will provide market projections, company analysis and testing product trends for this emerging market. NAT testing, molecular prenatal testing, pharmacogenomics, infectious disease testing, are among the areas within molecular diagnostics.
Molecular Diagnostics Industry Research & Market Reports
-
Kalorama COVID-19 Update: Impact on Molecular Diagnostics, Serology, Critical Care Tests, Vaccines and Telehealth Markets
... economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. ... Read More
-
Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas
... the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular ... Read More
-
Molecular Cancer Diagnostics Market
... leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular ... Read More
-
The World Molecular Diagnostics Market, 8th Edition
... in clinical medicine that touches all aspects of healthcare including treatment decisions in terms of identifying antimicrobial resistant (AMR) infections at the earliest, companion diagnostics assisting in the evaluation of suitability of various cancer treatment ... Read More
-
The Market and Potential for Molecular Point of Care Diagnostic Tests
... diagnostics (IVD) market. Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical ... Read More
-
The Market for Library Preparation and Target Enrichment for Next-Generation Sequencing
... revenues and growth rates for 2017-2022 and NGS sample preparation revenues by geographic region for 2017 (North America, Europe, Asia-Pacific, rest-of-world). As NGS science continues to evolve, the report examines trends in the market, including ... Read More
-
Prenatal and Newborn Genetic Screening and Testing Markets (by Application [Carrier Testing, Prenatal Screening, Newborn Testing, Newborn Screening], by Type [Services, Kits] by Geographic Region)
... While many discoveries have been made about the causes of genetic disorders, there remains much more to learn before many of these discoveries can be used as clinical tests – but progress is also being ... Read More
-
IVD in China
... by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. This report provides the following market data: Market by ... Read More
-
Infectious Disease Diagnostic Testing: World Market Analysis of TB, Flu, HIV, Hepatitis, Strep A, Malaria, HPV, Blood Screening, STDs, ID/AST, HAI, Rapids and Other Test Products
... areas of infectious diseases in 25 countries and regions. Diseases and technology categories segmented and forecasted in this report include: Blood Screening Immunoassay Blood Screening NAT Influenza Tests Strep A Test RSV Testing Malaria Tests ... Read More
-
Global Direct-to-Consumer Genetic Testing
... dollars at the manufacturer level. Major world regions include: USA, Europe, Asia/Pacific, and Rest of World. To illustrate historical trends, global demand is provided for 2015 and 2016. Demand by region is provided for 2017. Read More
-
The Market and Potential for Molecular Point of Care Diagnostic Tests
... (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient ... Read More
-
The Market for Direct-to-Consumer Genetic Health Testing
... 2017-2022; revenues and growth for the U.S. European, Asia Pacific, and rest of world DTC genetic testing market, 2017-2022; genetic testing market drivers and barriers; and global DTC genetic testing market analysis featuring genetic testing ... Read More
-
Inherited Disease and Molecular Diagnostics Bundle 2017
Bundle of report sections including Molecular Assay Procedures Inherited Disease Markets Cancer Markers Read More
-
Expected High Growth Market Segments in Molecular Diagnostic Testing
... Kalorama Information. will exceed the average for revenue growth in molecular IVD, according to a new Kalorama Information report. Average molecular IVD products will see six percent growth, the areas identified will be higher, over ... Read More
-
HIV Testing Market (Immunoassay, Molecular, Point-of-Care [POC])
... at manufacturer level) Global HIV Testing Market Share Percent by Test Category, 2017 (%; Lab-based, Molecular, POC) Global HIV Testing Market Share Percent by Test Category, 2022 (%; Lab-based, Molecular, POC) The three categories of ... Read More
-
Selected New Products in IVD
New products in IVD, as launched at major diagnostic conventions. Read More
-
The Market for Inherited Disease Molecular Diagnostic Testing
... as well as determine the risk of disease manifestation or progression. Point mutations in genomic DNA occur when a single nucleotide (A,T,C, or G) sequence is altered. Many SNPs have no effect on cell function, ... Read More
-
The Top 25 IVD Companies: Revenue Performance, Products, Strategies, Market Activities
... the most recent trends and developments. Companies included are: Alere Inc. Arkray Beckman Coulter / Danaher Becton Dickinson Bio-Rad Laboratories bioMérieux Cepheid / Danaher Danaher Corp. (including Radiometer A/S) Grifols Hologic Illumina Instrumentation Laboratory / ... Read More
-
IVD Trends Fall 2017
Trends in IVD Fall of 2017 Read More
-
The Worldwide Market for Laboratory-Developed Tests: Services (Labs Performing LDTs) and Equipment (Instruments and Reagents Used in LDTs)
... Two separate but related markets are discussed in this report: the market for clinical laboratory services using laboratory developed tests, and the market for products (platforms and consumables) sold to clinical laboratories who uses these ... Read More
-
Kalorama Information 2017 Regional IVD Market Bundle
... Markets (2017 Mexico IVD Markets (2017) India IVD Market (2016) This Kalorama Information Bundle is designed to provide cost savings to market researchers by providing several of our popular reports in one package. This report, ... Read More
-
Healthcare-Associated Infection Testing (HAI) - The "Prevention Effect" on Diagnostic Markets
... from patients with communicable infectious diseases. Infections, which may result from activities and procedures taking place within the facility, have become a cause for great concern. Infection that is acquired during the course of healthcare ... Read More
-
Hepatitis Testing Markets
... and Others) Key Trends in the Market Geographic Breakout of Market (US, ROW) Company Profiles HCV in particular is a driver of sales in this market. While HCV infections are increasingly caught and treated among ... Read More
-
What's Trending in IVD - June 2017
-
Transplant Matching Molecular Diagnostics Market
... same patient (donor and recipient) is increasingly common and eliminates the need to screen for histocompatibility. However, solid organ transplants and HSCT allografts from another donor requires histocompatibility confirmed by human leukocyte antigen (HLA) testing ... Read More
Research Assistance
